Company Cash Funds: Regencell Bioscience Holdings Limited (RGC)

RGC (Regencell) - company brandmark

The current cash position demonstrates the potential of Regencell Bioscience (RGC), a biotech firm developing natural chemical analogs for autism therapy based on Chinese medicine. The value of 0.01 aligns with current metrics while the company sustains losses due to a lack of sales, focusing instead on securing global patents and completing early-stage clinical trials for its neuropsychiatric platforms.

RGC - Regencell Bioscience Ltd Company Cash on Hand over the range 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Regencell Bioscience Ltd (RGC)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:regencellbioscience.com
Brand item of Regencell Bioscience Holdings Limited

This metric measures the volume of liquid assets, allowing investors to differentiate systemic reserve accumulation from short-term cash inflows. By analyzing cash flow dynamics, one can assess the ability of Regencell Bioscience (RGC) to fund the creation of strategic plant-based raw material reserves to mitigate logistical disruptions and ensure supply chain continuity without resorting to external debt capital.

Competitors of Regencell Bioscience

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Axsome Therapeutics AXSM|Company Cash Volume ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Company Cash Volume|Company Cash Reserve Viking Therapeutics|SUPN: Company Cash Volume|Catalyst Pharmaceuticals (CPRX) - Company Cash Volume|Company Cash on Hand DNLI|Company Cash and Cash Equivalents HRMY (Harmony Biosciences Holdings, Inc.)|Company Cash Funds Biohaven Ltd. (BHVN)|Company Total Cash Amount AMLX|Company Cash Funds trevitherapeutics.com TRVI|PRAX - Company Cash on Hand|Anavex Life Sciences Corp - Company Cash Volume|Company Cash Reserve CeriBell Corp|Prothena Corporation PLC (PRTA) - Company Cash Funds|Alector Therapeutics - Company Cash Balance|Company Cash Funds Annexon Biosciences|Company Cash Reserve omeros.com OMER|Company Cash Funds Neurogene (NGNE)|Company Liquid Assets AC Immune S.A.|Company Cash Volume VYGR (Voyager Therapeutics Inc)|Company Cash Balance NMRA|scilexholding.com - Company Cash Volume|TVGN (tevogen.com) - Company Cash and Cash Equivalents|ACOG: Company Cash Volume|CGTX: Company Total Cash Amount|Company Cash Funds Inhibikase Therapeutics|Company Cash and Cash Equivalents SAVA (Cassava)|Company Cash Funds Assertio Therapeutics (ASRT)|Coya Therapeutics - Company Cash and Cash Equivalents|VistaGen Therapeutics, Inc. - Company Cash on Hand|ovidrx.com (OVID) - Company Cash Reserve|ABOS: Company Cash on Hand|Company Cash Reserve CervoMed Inc|alteritytherapeutics.com (ATHE) - Company Cash Funds|Company Cash on Hand Clene Nanomedicine|Company Cash on Hand PEPG|Company Cash Reserve Jupiter Neurosciences JUNS|Company Cash Funds Relmada (RLMD)|Company Liquid Assets Annovis Bio, Inc.|Company Cash Volume GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Company Cash Reserve|KLTO - Company Cash Funds|Company Cash Reserve NeuroSense Therapeutics Ltd|RVPH: Company Cash Volume|MetaVia, Inc. (MTVA) - Company Cash Volume|Company Cash Funds NeurAxis|Company Cash Volume heliusmedical.com|Company Cash on Hand PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Company Cash and Cash Equivalents|Minerva Neurosciences Corp - Company Cash on Hand|Company Cash Balance ATHA|ADXN - Company Cash Funds|Company Cash Reserve Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Company Cash Funds|Company Cash and Cash Equivalents PTIX|KTTA (pasitheaclinics.com) - Company Cash Volume|CRGT (cortigent.com) - Company Total Cash Amount|Company Cash Volume ATXI|Company Cash Funds BCLI (Brainstorm Cell)|Company Cash Volume CARA (Cara Therapeutics Inc)|Company Cash Balance CHRO|Eliem Therapeutics Inc. - Company Cash Volume|ITCI - Company Cash Volume|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE